Life Sciences – Weekly Industry News

(BW) Teva and Mylan Settle Copaxone(R) Patent Litigation in France, the UK and the Netherlands, Posted on The Wall Street Journal JERUSALEM–(BUSINESS WIRE)–November 25, 2013–  Teva Pharmaceutical Industries (NYSE:TEVA) and Mylan Inc. (NASDAQ:MYL) today announce that certain of their affiliates have agreed to settle and dismiss pending patent litigation involving Copaxone(R) (glatiramer acetate) in the United…